NEWS9 January 2025
All MRS websites use cookies to help us improve our services. Any data collected is anonymised. If you continue using this site without accepting cookies you may experience some performance issues. Read about our cookies here.
NEWS9 January 2025
UK – Global healthcare market research company Purdie Pascoe has appointed Hazel Haskayne as director in its primary market research division.
Haskayne (pictured) has previously worked at firms including at Oracle Health & Life Sciences, Kantar, TNS and Engage Research, with more than 25 years of experience in healthcare market research.
In addition, Haskayne has experience across multiple therapy areas, including in oncology and rare diseases.
At Purdie Pascoe, Haskayne will work closely with the global primary market research teams to nurture existing client partnerships and seek to boost Purdie Pascoe’s pharmaceutical services and recognition within the market.
Stephen Potts, director at Purdie Pascoe, said: “I am delighted to welcome Hazel to the team. She is a market research expert with significant experience in the industry and brings a wealth of knowledge to the business.
“I look forward to collaborating with Hazel to strengthen our pharma market research offerings and deliver the best possible insights for our valued clients.”
0 Comments